Display options
Share it on

Toxicol Res. 2010 Dec;26(4):315-20. doi: 10.5487/TR.2010.26.4.315.

Toluene induces depression-like behaviors in adult mice.

Toxicological research

Miyoung Yang, Sung-Ho Kim, Jong-Choon Kim, Taekyun Shin, Changjong Moon

Affiliations

  1. Departments of Veterinary Anatomy and Veterinary Toxicology, College of Veterinary Medicine,Chonnam National University, Gwangju 500-757.

PMID: 24278539 PMCID: PMC3834495 DOI: 10.5487/TR.2010.26.4.315

Abstract

It has been clinically reported that toluene causes mental depression in humans. However, the detrimental effects of toluene exposure on brain function and the relation between features of mental depression and toluene exposure are poorly understood. This study evaluated depression-like behaviors in adult C57BL/6 mice after administration of toluene, and elucidated the effects of classical antidepressants on the depression-like behaviors. For the estimation of depression-like behaviors, tail suspension test (TST) and forcedswim test (FST) were performed 1, 4 and 16 days after toluene (0~1000 mg/kg bw) treatment. In addition, classical antidepressants such as fluoxetine (FLX, 20 mg/kg bw) and imipramine (IMI, 40 mg/kg bw) were administered 12 h and 1 h before the tests. In the TST and FST, toluene-treated mice exhibited a longer duration of immobility than vehicle-treated mice 1 and 4 days after toluene treatment. The depression-like behaviors were significantly reversed by FLX and IMI. The weight of the adrenal gland and the size of adrenocortical cells were significantly higher in toluene-treated mice compared to vehicle-treated controls. It is suggested that acute toluene exposure of adult mice is sufficiently detrimental to induce depression. In addition, this study has established a mouse model for a depressive state induced by toluene treatment.

Keywords: Adrenal gland; Animal model; Behavior; Depression; Toluene

References

  1. Sci Total Environ. 1985 Apr;42(3):267-88 - PubMed
  2. Pharmacol Biochem Behav. 2003 Mar;74(4):997-1003 - PubMed
  3. Pharmacol Biochem Behav. 2010 Feb;94(4):588-94 - PubMed
  4. Psychopharmacology (Berl). 2009 Jun;204(2):279-86 - PubMed
  5. Science. 1996 Nov 1;274(5288):740-3 - PubMed
  6. Pharmacol Biochem Behav. 1995 May;51(1):97-101 - PubMed
  7. Arch Int Pharmacodyn Ther. 1977 Oct;229(2):327-36 - PubMed
  8. Food Chem Toxicol. 1984 Oct;22(10):819-52 - PubMed
  9. Pharmacol Toxicol. 1999 Jul;85(1):37-43 - PubMed
  10. J Occup Rehabil. 2009 Dec;19(4):354-63 - PubMed
  11. Am J Psychiatry. 1995 Jun;152(6):833-42 - PubMed
  12. Neurobiol Learn Mem. 2010 May;93(4):487-94 - PubMed
  13. Life Sci. 2005 Mar 11;76(17):1929-37 - PubMed
  14. Exp Neurol. 2000 May;163(1):1-8 - PubMed
  15. Occup Med (Lond). 2003 Oct;53(7):479-82 - PubMed
  16. J Clin Psychiatry. 2003;64 Suppl 7:17-23 - PubMed
  17. Eur J Neurosci. 2008 Oct;28(8):1618-28 - PubMed
  18. Psychopharmacology (Berl). 1985;85(3):367-70 - PubMed
  19. Immunopharmacology. 1991 Jan-Feb;21(1):23-31 - PubMed
  20. Psychiatr Prax. 2007 Sep;34 Suppl 3:S256-60 - PubMed
  21. Am Fam Physician. 2003 Sep 1;68(5):869-74 - PubMed
  22. J Radiat Res. 2008 Sep;49(5):517-26 - PubMed
  23. Neurotoxicology. 1981 Nov;2(3):567-88 - PubMed
  24. Metab Brain Dis. 2010 Jun;25(2):169-76 - PubMed
  25. Eur J Pharmacol. 2004 Oct 1;500(1-3):371-84 - PubMed
  26. Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):207-14 - PubMed

Publication Types